Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of HS-10374 tablets in adults with active psoriatic arthritis
CTR20233854Phase 2Terminated
- Sponsor
- Changzhou Hengbang Pharmaceutical
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10374 in psoriatic arthritis (PsA), sponsored by Changzhou Hengbang Pharmaceutical. Started Mar 2024; status: terminated.
02
Drugs
HS-10374
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on CTR20233854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233854.